Evidence map›Paper›PMID 32047668›Full record

ArticleBiochemistry research international2020

miR-142-5p as a CXCR4-Targeted MicroRNA Attenuates SDF-1-Induced Chondrocyte Apoptosis and Cartilage Degradation via Inactivating MAPK Signaling Pathway.

Yaoyv Xiang, Yanlin Li, Lingjian Yang, Yinghong He, Di Jia, Xidan Hu

Open access · goldAbstract read
In one paragraph

Article in Biochemistry research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of theHeliyon · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Serum Levels of CXCR4, SDF-1, MCP-1, NF-κB and ERK1/2 in Patients with Skeletal Fluorosis.International journal of environmental research and public health · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yaoyv XiangDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650000, China.
Yanlin LiDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650000, China.ORCID https://orcid.org/0000-0001-9287-9013
Lingjian YangDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650000, China.
Yinghong HeDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650000, China.
Di JiaDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650000, China.
Xidan HuDepartment of Pharmacy, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650000, China.
Kunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a chronic joint function disorder with characteristics of chondrocytes reduction and extracellular matrix (ECM) components destruction. MicroRNAs (miRNAs) and the SDF-1/CXCR4 axis are essential factors of chondrocyte apoptosis and ECM degeneration. However, very few studies have investigated the correlation between miRNAs and the SDF-1/CXCR4 axis in osteoarthritis so far. Here, through miRNAs microarray and bioinformatics analyses, we identified miR-142-5p as a CXCR4-targeted and dramatically downregulated miRNA in cartilage from OA patients, as well as in SDF-1-induced OA chondrocytes

Identifiers

PMID32047668
PMCPMC7003277
OpenAlexW3001185022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.